New eye treatment combo tested against standard therapy
Disease control
Completed
This completed study tested whether adding a second drug (B55R2) to an existing treatment (B55R1) works better than using the single drug alone for diabetic retinopathy. Researchers followed 52 adults with non-proliferative diabetic retinopathy for 24 weeks, measuring changes in …
Phase: PHASE4 • Sponsor: AJU Pharm Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC